(APH) Amphenol - Ratings and Ratios
Connectors, Cables, Sensors, Interconnect Systems, Fiber Optic Products
APH EPS (Earnings per Share)
APH Revenue
Description: APH Amphenol
Amphenol Corporation is a leading global designer, manufacturer, and marketer of electrical, electronic, and fiber optic connectors. The companys diverse product portfolio includes connectors and connector systems, busbars, power distribution systems, and sensor-based products, catering to a wide range of industries such as automotive, aerospace, and mobile networks.
With a strong presence in the global market, Amphenol operates through three key segments: Harsh Environment Solutions, Communications Solutions, and Interconnect and Sensor Systems. This diversified business model enables the company to capitalize on emerging trends and technologies, driving growth and revenue.
Key performance indicators (KPIs) that highlight Amphenols financial health and operational efficiency include a market capitalization of $119.46 billion, indicating its significant market presence. The companys return on equity (ROE) stands at 27.13%, demonstrating its ability to generate profits from shareholder equity. Additionally, the forward price-to-earnings (P/E) ratio is 37.88, suggesting that the market expects the company to maintain its growth momentum.
From a growth perspective, Amphenols revenue is driven by its strong relationships with original equipment manufacturers (OEMs), electronic manufacturing services (EMS) companies, and original design manufacturers (ODMs). The companys global footprint, with operations in the United States, China, and other international markets, further enhances its growth prospects.
To gauge Amphenols stock performance, technical indicators such as the 20-day simple moving average (SMA20) at $97.05 and the 50-day SMA at $91.16 can be used to identify trends and potential buy/sell signals. With a current price of $99.44, the stock is trading near its 52-week high of $100.21, indicating a strong upward momentum.
Additional Sources for APH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
APH Stock Overview
Market Cap in USD | 119,460m |
Sector | Technology |
Industry | Electronic Components |
GiC Sub-Industry | Electronic Components |
IPO / Inception | 1991-11-08 |
APH Stock Ratings
Growth Rating | 90.9 |
Fundamental | 58.8 |
Dividend Rating | 62.5 |
Rel. Strength | 40.3 |
Analysts | 4.06 of 5 |
Fair Price Momentum | 114.70 USD |
Fair Price DCF | 11.43 USD |
APH Dividends
Dividend Yield 12m | 0.77% |
Yield on Cost 5y | 2.73% |
Annual Growth 5y | 16.17% |
Payout Consistency | 93.8% |
Payout Ratio | 31.1% |
APH Growth Ratios
Growth Correlation 3m | 98.9% |
Growth Correlation 12m | 66.7% |
Growth Correlation 5y | 93.9% |
CAGR 5y | 33.33% |
CAGR/Max DD 5y | 1.16 |
Sharpe Ratio 12m | 1.71 |
Alpha | 39.44 |
Beta | 1.663 |
Volatility | 18.70% |
Current Volume | 5281k |
Average Volume 20d | 7266.1k |
Stop Loss | 98.9 (-3%) |
As of July 19, 2025, the stock is trading at USD 101.96 with a total of 5,280,958 shares traded.
Over the past week, the price has changed by +3.71%, over one month by +9.87%, over three months by +56.99% and over the past year by +60.23%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Amphenol (NYSE:APH) is currently (July 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.81 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of APH is around 114.70 USD . This means that APH is currently undervalued and has a potential upside of +12.5% (Margin of Safety).
Amphenol has received a consensus analysts rating of 4.06. Therefore, it is recommended to buy APH.
- Strong Buy: 8
- Buy: 4
- Hold: 5
- Sell: 1
- Strong Sell: 0
According to our own proprietary Forecast Model, APH Amphenol will be worth about 136.4 in July 2026. The stock is currently trading at 101.96. This means that the stock has a potential upside of +33.73%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 92 | -9.7% |
Analysts Target Price | 91.4 | -10.4% |
ValueRay Target Price | 136.4 | 33.7% |